Abstract:Objective The study consisted of two parts: in part Ⅰ the effects of propofol or/and procaine on CD18, CD62L expression and superoxide anion (SOA) release of phorbol 12-myristal 13-acetate(PMA) stimulated human neutrophils (PMNs) were studied in vitro; in part Ⅱ the effects of propofol or/and procaine on IL-6 and TNF-αproduction in endotoxin-stimulated human whole blood were studied. Methods PMNs were separated from the whole blood obtained from healthy 20-40yr old subjects. Part Ⅰ consisted of 9 groups: in group 1 (control) phosphate buffer solution was added to PMNs; in group 2 PMNs were stimulated by PMA 100mg·ml-1 ; in group 3-5 different concentrations of propofol (0.4, 4.0,40μg·ml-1) were added to PMA stimulated PMNs; in group 6-8 different concentrations of procaine (1.5,15,150μg·ml-1 ) were added to PMA stimulated PMNs; in group 9 propofol 2μg·ml-1 and procaine 8μg·ml-1 were added to PMA stimulated PMNs. Part II also consisted of 9 groups: in groupl whole blood was mixed with normal saline; in group2 lipopolysaccharide (LPS) lμg·ml-1 was added to whole blood; in group 3-5 different concentrations of propofol (0.4,4.0,40μg·ml-1) were added to LPS stimulated whole blood; in group 6-8 different concentrations of procaine (1.5, 15, 150μg·ml-1 ) were added to LPS stimulated whole blood; in group 9 propofol 2μg·ml-1 and procaine 8μg·ml-1 were added to LPS stimulated whole blood. CD18, CD62L expressions were measured by flow cytometry. SOA release was determined by cytochrome C reduction in the presence or absence of superoxide dismutase (SOD) . IL-6 and TNF-α production were measured by using radioimmunoassay. Results Propofol or/and procaine depressed CD18 up-regulation, CD62L shedding and SOA release of PMA-stimulated PMNs and propofol was more effective than procaine. Propofol enhanced but procaine inhibited the increased production of TNF-α and IL-6 in the LPS stimulated whole blood but when propofol and procaine were used in combination. The effectof procaine predominated. Conclusions Propofol or/and procaine can attenuate tissue damage induced by neutrophils by inhibiting the function of neutrophils.

Anesthetic Agent Propofol Inhibits Myeloid Differentiation Factor 88-Dependent and Independent Signaling and Mitigates Lipopolysaccharide-Mediated Reactive Oxygen Species Production in Human Neutrophils in Vitro.

MOLECULAR MECHANISMS OF PROPOFOL-INVOLVED SUPPRESSION OF NO BIOSYNTHESIS AND INDUCIBLE iNOS GENE EXPRESSION IN LPS-STIMULATED MACROPHAGE-LIKE RAW 264.7 CELLS

Propofol pretreatment attenuates LPS-induced granulocyte–macrophage colony-stimulating factor production in cultured hepatocytes by suppressing MAPK/ERK activity and NF-κB translocation

Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1

Propofol inhibits the activation of p38 through up-regulating the expression of annexin A1 to exert its anti-inflammation effect

Propofol metabolites and derivatives inhibit the oxidant activities of neutrophils and myeloperoxidase

The effect of propofo1 or/and procaine on human neutrophil function

Peucedanum Praeruptorum Dunn Polysaccharides Regulate Macrophage Inflammatory Response Through TLR2/TLR4-mediated MAPK and NF-κB Pathways.

Propofol Inhibits Microglial Activation Via Mir-106B/pi3k/akt Axis.

Propofol Protects Rats and Human Alveolar Epithelial Cells Against Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting HMGB1 Expression

A CRTH2 Antagonist, CT-133, Suppresses NF-κB Signalling to Relieve Lipopolysaccharide-Induced Acute Lung Injury.

Inhibition of Myosin Light-Chain Kinase Enhances the Clearance of Lipopolysaccharide-Induced Lung Inflammation Possibly by Accelerating Neutrophil Apoptosis.

Propofol inhibits endogenous formyl peptide-induced neutrophil activation and alleviates lung injury

Delayed Treatment of Propofol Inhibits Lipopolysaccharide-Induced Inflammation in Microglia Through the PI3K/PKB Pathway.

NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity.

Protective Effects of Polydatin on Lipopolysaccharide-Induced Acute Lung Injury Through TLR4-MyD88-NF-κB Pathway

Posttreatment with propofol attenuates lipopolysaccharide-induced up-regulation of inflammatory molecules in primary microglia

Effects of propofol against LPS-induced inflammation injury of Ana-1 cells

Propofol regulates activated macrophages metabolism through inhibition of ROS-mediated GLUT1 expression

Pudilan Xiaoyan Oral Liquid Alleviates LPS-induced Respiratory Injury Through Decreasing Nitroxidative Stress and Blocking TLR4 Activation along with NF-ΚB Phosphorylation in Mice

Pivotal role of reactive oxygen species in differential regulation of lipopolysaccharide-induced prostaglandins production in macrophages.